Wei-Ming Kao is an Oncology physician affiliated with Bristol-Myers Squibb. OpenAlex indexes 22 publications with 1,791 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- MM-1119: Arlocabtagene Autoleucel in Patients With Heavily Pretreated Relapsed/Refractory Multiple Myeloma: Final Analysis From the Phase 1 Study
Clinical Lymphoma Myeloma & Leukemia
2026 - POSTER: MM-1119: Arlocabtagene Autoleucel in Patients With Heavily Pretreated Relapsed/Refractory Multiple Myeloma: Final Analysis From the Phase 1 Study
Clinical Lymphoma Myeloma & Leukemia
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Yixin Li
Bristol-Myers Squibb
Alan J. Korman
Bristol-Myers Squibb
Robert Plenge, MD
Bristol-Myers Squibb
Ray Hershberger, MD
Bristol-Myers Squibb
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”